Annelie Wünsche advises and represents companies in prosecuting patent and utility model applications and defending and challenging acquired IP rights in the areas of biochemistry, biotechnology and pharmaceuticals. In particular, she advises and supports public research institutes and biotechnology companies in building patent portfolios and advises generics companies on market entry. Further key activities relate to the support of due diligence projects and the acquisition of supplementary protection certificates.
Annelie spent several months on secondment to a publicly listed biotechnology company in helping establish a patent portfolio in the area of immune therapy. Before entering the world of patent law, she gained valuable experience in industry from working in a pharma concern in the field of therapeutic antibodies, and in an optics and medical technology concern developing microscopy software.
Year Joined Firm: 2011
Education/Alumni:
- 2023 Admitted to practice before the UPC
- Since 2017 Authorized to represent before the Austrian Patent Office
- 2016 Admitted to practice as European patent attorney
- 2014 Admitted to practice as German patent attorney
- 2011 - 2013 Studied law for patent attorneys at the University of Hagen
- 2007 - 2011 Doctoral degree in the field of cell biology from Heidelberg University (doctoral research at the European Molecular Biology Laboratory Heidelberg (EMBL) with research stint at the Research Institute of Molecular Biology (IMP))
- 2002 - 2007 Studied biology at the Ludwig Maximilian University of Munich
Network Memberships:
- German Patent Attorney Association
- epi
